Sign Up to like & get
recommendations!
1
Published in 2022 at "Chembiochem"
DOI: 10.1002/cbic.202200180
Abstract: Histone deacetylases (HDACs) are important epigenetic regulators involved in many diseases, especially cancer. Five HDAC inhibitors have been approved for anticancer therapy and many are in clinical trials. Among the 11 zinc‐dependent HDACs, HDAC10 has…
read more here.
Keywords:
assay hdac10;
deacetylation;
cellular target;
target engagement ... See more keywords